BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31235785)

  • 1. Upregulation of IL-6 in CUL4B-deficient myeloid-derived suppressive cells increases the aggressiveness of cancer cells.
    Xu Z; Li L; Qian Y; Song Y; Qin L; Duan Y; Wang M; Li P; Jiang B; Ma C; Shao C; Gong Y
    Oncogene; 2019 Jul; 38(30):5860-5872. PubMed ID: 31235785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CUL4B/AKT/β-Catenin Axis Restricts the Accumulation of Myeloid-Derived Suppressor Cells to Prohibit the Establishment of a Tumor-Permissive Microenvironment.
    Qian Y; Yuan J; Hu H; Yang Q; Li J; Zhang S; Jiang B; Shao C; Gong Y
    Cancer Res; 2015 Dec; 75(23):5070-83. PubMed ID: 26450912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Apc
    Guo B; Zheng Y; Fan Y; Yang Y; Wang Y; Qin L; An Y; Xu X; Zhang X; Sun G; Dou H; Shao C; Gong Y; Jiang B; Hu H
    Neoplasia; 2024 Jul; 53():101005. PubMed ID: 38761506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor NLRP3-Derived IL-1β Drives the IL-6/STAT3 Axis Resulting in Sustained MDSC-Mediated Immunosuppression.
    Tengesdal IW; Dinarello A; Powers NE; Burchill MA; Joosten LAB; Marchetti C; Dinarello CA
    Front Immunol; 2021; 12():661323. PubMed ID: 34531850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Mll1-Complex by Stat3/Cebpβ-Induced miR-21a/21b/181b Maintains the Accumulation, Homeostasis, and Immunosuppressive Function of Polymorphonuclear Myeloid-Derived Suppressor Cells.
    Zhang Z; Huang X; Wang E; Huang Y; Yang R
    J Immunol; 2020 Jun; 204(12):3400-3415. PubMed ID: 32358019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model.
    Oh K; Lee OY; Shon SY; Nam O; Ryu PM; Seo MW; Lee DS
    Breast Cancer Res; 2013; 15(5):R79. PubMed ID: 24021059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis.
    Neo SY; Tong L; Chong J; Liu Y; Jing X; Oliveira MMS; Chen Y; Chen Z; Lee K; Burduli N; Chen X; Gao J; Ma R; Lim JP; Huo J; Xu S; Alici E; Wickström SL; Haglund F; Hartman J; Wagner AK; Cao Y; Kiessling R; Lam KP; Westerberg LS; Lundqvist A
    Sci Transl Med; 2024 May; 16(747):eadi2952. PubMed ID: 38748775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma.
    Zhao Q; Huang L; Qin G; Qiao Y; Ren F; Shen C; Wang S; Liu S; Lian J; Wang D; Yu W; Zhang Y
    Cancer Lett; 2021 Oct; 518():35-48. PubMed ID: 34139285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models.
    Sahraei M; Bose M; Sanders JA; De C; DasRoy L; Nath S; Brouwer CR; Mukherjee P
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3.
    Tang Q; Jiang J; Liu J
    Inflammation; 2015 Dec; 38(6):2049-56. PubMed ID: 26047948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid-derived suppressor cells accumulate among myeloid cells contributing to tumor growth in matrix metalloproteinase 12 knockout mice.
    Li J; Zhang X; Liu Q; Yang M; Zhou Z; Ye Y; Zhou Z; He X; Wang L
    Cell Immunol; 2018 May; 327():1-12. PubMed ID: 29555056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced LPS-induced peritonitis in mice deficiency of cullin 4B in macrophages.
    Hung MH; Jian YR; Tsao CC; Lin SW; Chuang YH
    Genes Immun; 2014 Sep; 15(6):404-12. PubMed ID: 24898386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10 attenuates tumour growth by inhibiting interleukin-6/signal transducer and activator of transcription 3 signalling in myeloid-derived suppressor cells.
    Lee BR; Kwon BE; Hong EH; Shim A; Song JH; Kim HM; Chang SY; Kim YJ; Kweon MN; Youn JI; Ko HJ
    Cancer Lett; 2016 Oct; 381(1):156-64. PubMed ID: 27431309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CUL4B renders breast cancer cells tamoxifen-resistant via miR-32-5p/ER-α36 axis.
    Wang Y; Pan X; Li Y; Wang R; Yang Y; Jiang B; Sun G; Shao C; Wang M; Gong Y
    J Pathol; 2021 Jun; 254(2):185-198. PubMed ID: 33638154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
    Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
    Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CUL4B negatively regulates Toll-like receptor-triggered proinflammatory responses by repressing Pten transcription.
    Song Y; Li P; Qin L; Xu Z; Jiang B; Ma C; Shao C; Gong Y
    Cell Mol Immunol; 2021 Feb; 18(2):339-349. PubMed ID: 31729464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
    Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P
    J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.
    Adeshakin AO; Liu W; Adeshakin FO; Afolabi LO; Zhang M; Zhang G; Wang L; Li Z; Lin L; Cao Q; Yan D; Wan X
    Cell Immunol; 2021 Apr; 362():104286. PubMed ID: 33524739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual negative roles of C/EBPα in the expansion and pro-tumor functions of MDSCs.
    Mackert JR; Qu P; Min Y; Johnson PF; Yang L; Lin PC
    Sci Rep; 2017 Oct; 7(1):14048. PubMed ID: 29070836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.